Prediction of ovarian endometriosis recurrence and its neoplastic transformation
article
OA: closed
CC0
⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study developed and validated a nomogram to predict the likelihood of ovarian endometriosis recurrence and its subsequent neoplastic transformation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (12)
- Age-related differences in the sonographic characteristics of endometriomas via openalex
- Evaluation of the Ki-67 Proliferation Index and Urocortin Expression in Women with Ovarian Endometriomas via openalex
- Imaging modalities for the non-invasive diagnosis of endometriosis via openalex
- Pathology of endometriosis. via openalex
- Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany via openalex
- The Dichotomy in the Histogenesis of Endometriosis-associated Ovarian Cancer via openalex
- W3142150957 via openalex
- W563045379 via openalex
- W1577593758 via openalex
- W1829991870 via openalex
- W2019601632 via openalex
- W2125681453 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK